Overview

Update
IPO / Stock
Went Public on Sep 18, 2013 / NASDAQ:FPRX
Total Equity Funding
$62.5M in 4 Rounds from 11 Investors
Headquarters:
San Francisco, CA
Description:
FivePrime is dis­cov­er­ing and devel­op­ing novel ther­a­peu­tic pro­teins and anti­bod­ies
Founders:
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.fiveprime.com
Social:

Company Details

Update

FivePrime is dis­cov­er­ing and devel­op­ing novel ther­a­peu­tic pro­teins and anti­bod­ies by sys­tem­at­i­cally screen­ing all rel­e­vant pro­teins in the human body to find the best pro­tein for treat­ment of a given clin­i­cal indi­ca­tion. FivePrime’s Pro­Screen Engine enables the rapid pro­duc­tion and screen­ing of all ther­a­peu­ti­cally rel­e­vant pro­teins in medically-​​focused assays at the high­est qual­ity stan­dards in the indus­try. This pow­er­ful approach is the polar oppo­site of the industry’s tra­di­tional “one pro­tein at a time”. The Pro­Screen Engine com­prises the defin­i­tive pro­tein col­lec­tion and screen­ing process for bio­log­ics dis­cov­ery and is unprece­dented in its effi­ciency, qual­ity and scale. In addi­tion to DBL Investors, investors include Domain Asso­ciates, Ver­sant Ven­tures, Kleiner Perkins Cau­field and Byers, Texas Pacific Group, Health­Cap and Advanced Tech­nol­ogy Ventures.

Funding Rounds (6) - $145.54M

Update
DateAmount / RoundValuationLead InvestorInvestors
Mar, 2014$21.04M / Post Ipo Equity0
Sep, 2013$62M / Post Ipo Equity0
Apr, 2012$10M / Private Equity2
Sep, 2010$7.5M / Venture0
May, 2008undisclosed amount / Venture1
Feb, 2005$45M / Venture10

Current Team (12)

Update

Offices/Locations (2)

Update
  • Headquarters

    1650 Owens Street

    Suite 200

    San Francisco, CA 94158-2216

    USA

  • Two Corporate Drive

    South San Francisco, CA 94080

    USA

Past Team (3)

Update

Images (2)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos